From: Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis
Number of datasets | Number of people screened (total) | Number of test positive people | Intensity of infection | |||
---|---|---|---|---|---|---|
Low, % (95% CI) | Moderate, % (95% CI) | High, % (95% CI) | ||||
Global | ||||||
Central and Southern Asia | 8 | 20,771 | 5891 | 88.54 (73.39–98.19) | 9.43 (1.50–21.93) | 0.62 (0.01–0.63) |
Eastern and South-Eastern Asia | 36 | 405,721 | 7893 | 66.59 (56.04–76.45) | 24.67 (17.77–32.19) | 3.80 (1.07–7.59) |
Latin America and the Caribbean | 19 | 12,005 | 2769 | 55.96 (48.28–63.51) | 31.20 (24.01–38.88) | 8.35 (3.88–14.11) |
Sub-Saharan Africa | 81 | 143,231 | 14,642 | 83.31 (78.95–87.31) | 12.22 (9.15–15.59) | 0.26 (0.01–0.97) |
Year of publication | ||||||
2010–2013 | 31 | 26,710 | 4429 | 70.51 (59.43–80.57) | 20.93 (13.82–28.95) | 3.32 (1.11–6.31) |
2013–2017 | 50 | 72,982 | 13,153 | 77.94 (69.83–85.19) | 15.15 (10.16–20.80) | 1.41 (0.11–3.62) |
2018–2021 | 64 | 482,619 | 13,924 | 77.55 (72.13–82.59) | 17.78 (13.82–22.07) | 1.43 (0.44–2.79) |